CVE-2026-118450: Venere is installed outside Program Files and loads/registers unsigned components from locations
Source GCVE Database
Not known to be exploited · CVSS 5.9 Medium.
Data as of 9 Nov 2026, 13:04 UTC
Thin evidence
One scorer or none| CNA (ENISA) | CVSS 4.0 | 5.9 |
|---|
CVSS:4.0/AV:L/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:UExploitation evidence
Disclosed: evidence found.
CVE published 9 Nov 2026
Detectable: no evidence on record.
No public nuclei template indexed
Weaponized: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 9 Nov 2026.
What to do
Affected software
| Product | Affected | Fixed in |
|---|---|---|
| CompuGroup MedicalVenere | Affected
| Fixed in– |
AI-suggested
Until a fix is available, restrict write permissions to the directories where Venere loads components and consider relocating the installation to a more secure path such as Program Files. Monitor vendor communications for updates.
Description
Venere is installed outside the Program Files directory and loads or registers unsigned components from locations where unprivileged users can create files. This configuration introduces a security risk by allowing potential unauthorized code execution or privilege escalation through manipulation of these unsigned components.
References
- nvd.nist.gov/vuln/detail/CVE-2026-118450 (opens in a new tab)
- acn.gov.it/portale/w/rilevate-vulnerabilita-in-prodotti-compugroup-medical (opens in a new tab)
- cgm.com/ita_it/magazine/articles/comunicati-stampa/piu-sicurezza-per-farmacie-studi-medici-e-pazienti-cgm-italia-risolve-potenziali-vulnerabilita-software-insieme-a-csirt-italia.html (opens in a new tab)